- Home
- Companies
- usa colorado
- clinical outcomes
Refine by
Clinical Outcomes Suppliers In Usa Colorado
4 companies found
based inEnglewood, COLORADO (USA)
Paragon 28 was established in 2010 to address unmet and under-served needs of the foot and ankle community. We are dedicated to creating tailored solutions and tools to improve the treatment of even the most difficult foot and ankle conditions. ...
The APEX 3D System has been efficiently streamlined to accommodate surgeon preference and is equipped to address a wide range of arthritic ankle conditions. The APEX 3D System is based on over a century of combined clinical ...
based inArvada, COLORADO (USA)
Opus is a complete clinical solution that empowers clinicians to customize, measure, assess, and treat addiction, SUD, and behavioral health treatment centers. With everything in one place, we help you optimize the continuum of care – intake, ...
Our behavioral healthcare-specific EHR helps you document, track, and optimize patient care throughout their treatment journey. With AI-powered assistance, customizable workflows, and real-time insights, you can focus on what matters most - ...
based inTel Aviv, ISRAEL
Medinol is dedicated to the science of cardiovascular intervention. For over 20 years, we have delivered over two million coronary stents to patients worldwide. Medinol is dedicated to the science of cardiovascular intervention. For over 20 years, ...
Ridaforolimus Eluting Coronary Stent System; Excellent clinical outcomes. Redefining deliverability with a new spring tip. Low footprint cobalt-chromium design. Optimal conformability and vessel support. Elastomeric ...
based inLouisville, COLORADO (USA)
Colibri Heart Valve LLC (“Colibri”) is a privately held medical device company that researches and develops novel, patent protected, structural heart technologies. Colibri was formed in 2010 and is located near Boulder Colorado. Through Colibri’s ...
Colibri recently initiated a clinical early feasibility study (EFS) which is an international prospective, non-randomized, single arm, open label, trial to assess early feasibility of the Colibri second-generation 24mm and 27mm percutaneous, ...
